Advertisement

High-Grade Prostatic Intraepithelial Neoplasia

  • Rajal B. ShahEmail author
  • Ming Zhou
Chapter

Abstract

Prostatic intraepithelial neoplasia (PIN) is considered a precursor lesion to prostate carcinoma and a surrogate marker for cancer in prostate biopsies. It is characterized by secretory epithelial proliferation within the prostate glands and acini that display significant cytological atypia. PIN does not result in an abnormal digital rectal examination nor elevated serum prostate-specific antigen (PSA) level and can only be diagnosed by histological examination of the prostate tissue. Based on the degree of atypia, PIN can be categorized into low-grade (LGPIN) and high-grade PIN (HGPIN). The significance of a PIN diagnosis in biopsy is the cancer risk in follow-up repeat biopsies. LGPIN is not associated with increased cancer detection in follow-up repeat biopsies, and its diagnosis is not readily reproducible even among urologic pathologists; therefore, it should not be diagnosed and reported in prostate biopsy. The clinical significance and management of HGPIN diagnosed in needle biopsy have drastically changed in the last decade. The diagnosis carries a 20–30% cancer risk in subsequent biopsies, which is not significantly higher than the cancer risk associated with a benign or LGPIN diagnosis. Therefore, men with HGPIN involving a single biopsy core should be followed similar to men with benign results and do not need repeat biopsy. Men with HGPIN involving multiple cores have an increased risk of cancer compared with those with a benign or unifocal HGPIN. These patients are recommended for additional serum and urine biomarker testing and imaging studies to assess the risk of high-grade cancer, and the decision to perform repeat biopsy depends upon such risk assessment.

Keywords

Prostatic intraepithelial neoplasia PIN High-grade prostatic intraepithelial neoplasia HGPIN Luminal cell cytology α-Methylacyl-CoA racemase AMACR ERG Ductal adenocarcinoma Intraductal carcinoma of the prostate Cribriform HGPIN Basal cell hyperplasia Central zone glands Cancer risk associated with HGPIN PIN-like carcinoma Repeat biopsy strategy 

References

  1. 1.
    Bostwick DG, Qian J. High-grade prostatic intraepithelial neoplasia. Mod Pathol. 2004;17:360–79.CrossRefGoogle Scholar
  2. 2.
    Tosoian JJ, Alam R, Ball MW, Carter HB, Epstein JI. Managing high-grade prostatic intraepithelial neoplasia (HGPIN) and atypical glands on prostate biopsy. Nat Rev Urol. 2018;15:55–66.CrossRefGoogle Scholar
  3. 3.
    De Marzo AM, Haffner MC, Lotan TL, Yegnasubramanian S, Nelson WG. Premalignancy in prostate cancer: rethinking what we know. Cancer Prev Res (Phila). 2016;9:648–56.CrossRefGoogle Scholar
  4. 4.
    Humphrey PA. Prostate pathology. Chicago: ASCP Press; 2003. p. 186.Google Scholar
  5. 5.
    Bostwick DG, Amin MB, Dundore P, Marsh W, Schultz DS. Architectural patterns of high-grade prostatic intraepithelial neoplasia. Hum Pathol. 1993;24:298–310.CrossRefGoogle Scholar
  6. 6.
    Epstein JI. Precursor lesions to prostatic adenocarcinoma. Virchows Arch. 2009;454:1–16.CrossRefGoogle Scholar
  7. 7.
    Egevad L, Allsbrook WC, Epstein JI. Current practice of diagnosis and reporting of prostatic intraepithelial neoplasia and glandular atypia among genitourinary pathologists. Mod Pathol. 2006;19:180–5.CrossRefGoogle Scholar
  8. 8.
    Rubin MA, Zhou M, Dhanasekaran SM, Varambally S, Barrette TR, Sanda MG, et al. Alpha-Methylacyl coenzyme A racemase as a tissue biomarker for prostate cancer. JAMA. 2002;287:1662–70.CrossRefGoogle Scholar
  9. 9.
    Wu CL, Yang XJ, Tretiakova M, Patton KT, Halpern EF, Woda BA, et al. Analysis of alpha-methylacyl-CoA racemase (P504S) expression in high-grade prostatic intraepithelial neoplasia. Hum Pathol. 2004;35:1008–13.CrossRefGoogle Scholar
  10. 10.
    Furusato B, Tan SH, Young D, Dobi A, Sun C, Mohamed AA, et al. ERG oncoprotein expression in prostate cancer: clonal progression of ERG-positive tumor cells and potential for ERG-based stratification. Prostate Cancer Prostatic Dis. 2010;13:228–37.CrossRefGoogle Scholar
  11. 11.
    Park K, Tomlins SA, Mudaliar KM, Chiu YL, Esgueva R, Mehra R, et al. Antibody-based detection of ERG rearrangement-positive prostate cancer. Neoplasia. 2010;12:590–8.CrossRefGoogle Scholar
  12. 12.
    Perner S, Mosquera JM, Demichelis F, Hofer MD, Paris PL, Simko J, et al. TMPRSS2-ERG fusion prostate cancer: an early molecular event associated with invasion. Am J Surg Pathol. 2007;31:882–8.CrossRefGoogle Scholar
  13. 13.
    Godoy G, Taneja SS. Contemporary clinical management of isolated high-grade prostatic intraepithelial neoplasia. Prostate Cancer Prostatic Dis. 2008;11:20–31.CrossRefGoogle Scholar
  14. 14.
    Schlesinger C, Bostwick DG, Iczkowski KA. High-grade prostatic intraepithelial neoplasia and atypical small acinar proliferation: predictive value for cancer in current practice. Am J Surg Pathol. 2005;29:1201–7.CrossRefGoogle Scholar
  15. 15.
    Girasole CR, Cookson MS, Putzi MJ, Chang SS, Smith JA Jr, Wells N, et al. Significance of atypical and suspicious small acinar proliferations, and high grade prostatic intraepithelial neoplasia on prostate biopsy: implications for cancer detection and biopsy strategy. J Urol. 2006;175:929–33; discussion 933.CrossRefGoogle Scholar
  16. 16.
    Hameed O, Humphrey PA. Stratified epithelium in prostatic adenocarcinoma: a mimic of high-grade prostatic intraepithelial neoplasia. Mod Pathol. 2006;19:899–906.CrossRefGoogle Scholar
  17. 17.
    Tavora F, Epstein JI. High-grade prostatic intraepithelial neoplasialike ductal adenocarcinoma of the prostate: a clinicopathologic study of 28 cases. Am J Surg Pathol. 2008;32:1060–7.CrossRefGoogle Scholar
  18. 18.
    Guo CC, Epstein JI. Intraductal carcinoma of the prostate on needle biopsy: histologic features and clinical significance. Mod Pathol. 2006;19:1528–35.CrossRefGoogle Scholar
  19. 19.
    Han B, Suleman K, Wang L, Siddiqui J, Sercia L, Magi-Galluzzi C, et al. ETS gene aberrations in atypical cribriform lesions of the prostate: implications for the distinction between intraductal carcinoma of the prostate and cribriform high-grade prostatic intraepithelial neoplasia. Am J Surg Pathol. 2010;34:478–85.CrossRefGoogle Scholar
  20. 20.
    Shah RB, Zhou M. Atypical cribriform lesions of the prostate: clinical significance, differential diagnosis and current concept of intraduct al carcinoma of the prostate. Adv Anat Pathol. 2012;19:270–8.CrossRefGoogle Scholar
  21. 21.
    NCCN Clinical Practice Guidelines in Oncology: Prostate Cancer Early Detection, Version 2. 2018. https://www.nccn.org/professionals/physician_gls/pdf/prostate_detection.pdf. Accessed 23 July 2018.

Copyright information

© Springer Nature Switzerland AG 2019

Authors and Affiliations

  1. 1.Robert J Tomsich Pathology and Laboratory Medicine InstituteCleveland ClinicClevelandUSA
  2. 2.Tufts Medical CenterBostonUSA

Personalised recommendations